101 related articles for article (PubMed ID: 29402494)
1. Activation of bombesin receptor Subtype-3 by [D-Tyr
Moreno-Villegas Z; Martín-Duce A; Aparicio C; Portal-Núñez S; Sanz R; Mantey SA; Jensen RT; Lorenzo O; Egido J; González N
Mol Cell Endocrinol; 2018 Oct; 474():10-19. PubMed ID: 29402494
[TBL] [Abstract][Full Text] [Related]
2. Bombesin receptor subtype-3 (BRS-3), a novel candidate as therapeutic molecular target in obesity and diabetes.
Ramos-Álvarez I; Martín-Duce A; Moreno-Villegas Z; Sanz R; Aparicio C; Portal-Núñez S; Mantey SA; Jensen RT; González N
Mol Cell Endocrinol; 2013 Mar; 367(1-2):109-15. PubMed ID: 23291341
[TBL] [Abstract][Full Text] [Related]
3. Human BRS-3 receptor: functions/role in cell signaling pathways and glucose metabolism in obese or diabetic myocytes.
Ramos-Álvarez I; Moreno-Villegas Z; Martín-Duce A; Sanz R; Aparicio C; Portal-Núñez S; Mantey SA; Jensen RT; González N
Peptides; 2014 Jan; 51():91-9. PubMed ID: 24220502
[TBL] [Abstract][Full Text] [Related]
4. Effect of bombesin receptor subtype-3 and its synthetic agonist on signaling, glucose transport and metabolism in myocytes from patients with obesity and type 2 diabetes.
González N; Martín-Duce A; Martínez-Arrieta F; Moreno-Villegas Z; Portal-Núñez S; Sanz R; Egido J
Int J Mol Med; 2015 Apr; 35(4):925-31. PubMed ID: 25653074
[TBL] [Abstract][Full Text] [Related]
5. Functions of pancreatic beta cells and adipocytes in bombesin receptor subtype-3-deficient mice.
Nakamichi Y; Wada E; Aoki K; Ohara-Imaizumi M; Kikuta T; Nishiwaki C; Matsushima S; Watanabe T; Wada K; Nagamatsu S
Biochem Biophys Res Commun; 2004 Jun; 318(3):698-703. PubMed ID: 15144894
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis for agonist selectivity and activation of the orphan bombesin receptor subtype 3 receptor.
Gonzalez N; Hocart SJ; Portal-Nuñez S; Mantey SA; Nakagawa T; Zudaire E; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2008 Feb; 324(2):463-74. PubMed ID: 18006692
[TBL] [Abstract][Full Text] [Related]
7. Role of PDE3B in insulin-induced glucose uptake, GLUT-4 translocation and lipogenesis in primary rat adipocytes.
Zmuda-Trzebiatowska E; Oknianska A; Manganiello V; Degerman E
Cell Signal; 2006 Mar; 18(3):382-90. PubMed ID: 15961276
[TBL] [Abstract][Full Text] [Related]
8. Gly-Ala-Gly-Val-Gly-Tyr, a novel synthetic peptide, improves glucose transport and exerts beneficial lipid metabolic effects in 3T3-L1 adipoctyes.
Kim ED; Kim E; Lee JH; Hyun CK
Eur J Pharmacol; 2011 Jan; 650(1):479-85. PubMed ID: 20951125
[TBL] [Abstract][Full Text] [Related]
9. Effect of GLP-1 on D-glucose transport, lipolysis and lipogenesis in adipocytes of obese subjects.
Sancho V; Trigo MV; Martín-Duce A; Gonz Lez N; Acitores A; Arnés L; Valverde I; Malaisse WJ; Villanueva-Peñacarrillo ML
Int J Mol Med; 2006 Jun; 17(6):1133-7. PubMed ID: 16685426
[TBL] [Abstract][Full Text] [Related]
10. Effects of glucagon-like peptide-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats.
Sancho V; Trigo MV; González N; Valverde I; Malaisse WJ; Villanueva-Peñacarrillo ML
J Mol Endocrinol; 2005 Aug; 35(1):27-38. PubMed ID: 16087719
[TBL] [Abstract][Full Text] [Related]
11. A bombesin receptor subtype-3 peptide increases nuclear oncogene expression in a MEK-1 dependent manner in human lung cancer cells.
Weber HC; Walters J; Leyton J; Casibang M; Purdom S; Jensen RT; Coy DH; Ellis C; Clark G; Moody TW
Eur J Pharmacol; 2001 Jan; 412(1):13-20. PubMed ID: 11166731
[TBL] [Abstract][Full Text] [Related]
12. Obestatin inhibits lipogenesis and glucose uptake in isolated primary rat adipocytes.
Pruszynska-Oszmalek E; Szczepankiewicz D; Hertig I; Skrzypski M; Sassek M; Kaczmarek P; Kolodziejski PA; Mackowiak P; Nowak KW; Strowski MZ; Wojciechowicz T
J Biol Regul Homeost Agents; 2013; 27(1):23-33. PubMed ID: 23489684
[TBL] [Abstract][Full Text] [Related]
13. Rational design of a peptide agonist that interacts selectively with the orphan receptor, bombesin receptor subtype 3.
Mantey SA; Coy DH; Pradhan TK; Igarashi H; Rizo IM; Shen L; Hou W; Hocart SJ; Jensen RT
J Biol Chem; 2001 Mar; 276(12):9219-29. PubMed ID: 11112777
[TBL] [Abstract][Full Text] [Related]
14. Bombesin receptor subtype-3 (BRS-3) regulates glucose-stimulated insulin secretion in pancreatic islets across multiple species.
Feng Y; Guan XM; Li J; Metzger JM; Zhu Y; Juhl K; Zhang BB; Thornberry NA; Reitman ML; Zhou YP
Endocrinology; 2011 Nov; 152(11):4106-15. PubMed ID: 21878513
[TBL] [Abstract][Full Text] [Related]
15. Factors contributing to obesity in bombesin receptor subtype-3-deficient mice.
Ladenheim EE; Hamilton NL; Behles RR; Bi S; Hampton LL; Battey JF; Moran TH
Endocrinology; 2008 Mar; 149(3):971-8. PubMed ID: 18039774
[TBL] [Abstract][Full Text] [Related]
16. Bombesin receptor subtype 3 as a potential target for obesity and diabetes.
González N; Moreno P; Jensen RT
Expert Opin Ther Targets; 2015; 19(9):1153-70. PubMed ID: 26066663
[TBL] [Abstract][Full Text] [Related]
17. Effects of a new hypoglycemic agent A-4166 on glucose metabolism in rat adipocytes and muscle tissues.
Macho L; Ficková M; Zórad S; Seböková E; Klimes I
Gen Physiol Biophys; 1999 Sep; 18(3):293-303. PubMed ID: 10703745
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of the pharmacological difference between rat and human bombesin receptor subtype-3 (BRS-3).
Liu J; Lao ZJ; Zhang J; Schaeffer MT; Jiang MM; Guan XM; Van der Ploeg LH; Fong TM
Biochemistry; 2002 Jul; 41(28):8954-60. PubMed ID: 12102638
[TBL] [Abstract][Full Text] [Related]
19. Bombesin receptor subtype-3 agonists stimulate the growth of lung cancer cells and increase EGF receptor tyrosine phosphorylation.
Moody TW; Sancho V; di Florio A; Nuche-Berenguer B; Mantey S; Jensen RT
Peptides; 2011 Aug; 32(8):1677-84. PubMed ID: 21712056
[TBL] [Abstract][Full Text] [Related]
20. Biology and pharmacology of bombesin receptor subtype-3.
Majumdar ID; Weber HC
Curr Opin Endocrinol Diabetes Obes; 2012 Feb; 19(1):3-7. PubMed ID: 22157398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
